## SAC Proposal Key References (Mohd Suffian Azizan: GB Team, Project 1)

### Key References

Below are the list of references that form the literature foundation of this project, cited in the poster titled ***'Building An Asian Neoantigen Database for Cancer Vaccine Development'***.

1. Remco Nagel, Abhijeet Pataskar, Julien Champagne, Reuven Agami; *Boosting Antitumor Immunity with an Expanded Neoepitope Landscape*. Cancer Res 15 October 2022; 82 (20): 3637–3649. [Nagel et al., 2022](https://doi.org/10.1158/0008-5472)
2. Katsikis, P.D., Ishii, K.J. & Schliehe, C. *Challenges in developing personalized neoantigen cancer vaccines*. Nat Rev Immunol 24, 213–227 (2024). [Katsikis et al., 2023](https://doi.org/10.1038/s41577-023-00937-y)
3. Pan JW, Ragu M, Chan WQ, Hasan SN, Islam T, Teoh LY, Jamaris S, See MH, Yip CH, Rajadurai P, Looi LM, Taib NAM, Rueda OM, Caldas C, Chin SF, Lim J, Teo SH. *Clustering of HR + /HER2- breast cancer in an Asian cohort is driven by immune phenotypes*. Breast Cancer Res. 2024 Apr 22;26(1):67. [Pan et al., 2024](10.1186/s13058-024-01826-5)
4. Tawfik, S.M., Elhosseiny, A.A., Galal, A.A. et al. *Health inequity in genomic personalized medicine in underrepresented populations: a look at the current evidence*. Funct Integr Genomics 23, 54 (2023). [Tawfik et al., 2023](https://doi.org/10.1007/s10142-023-00979-4)
5. Xie, N., Shen, G., Gao, W. et al. *Neoantigens: promising targets for cancer therapy*. Sig Transduct Target Ther 8, 9 (2023). [Xie et al., 2023](https://doi.org/10.1038/s41392-022-01270-x)
